Clinical Edge Journal Scan

Low diversity in skin microbiome in infancy raises risk for atopic dermatitis in high-risk children


 

Key clinical point: A lower alpha diversity in infancy is associated with an increased risk for atopic dermatitis (AD) in children of parents with atopy.

Major finding: Overall, the skin microbiome at birth and 2 months of age was not associated with the subsequent development of AD (P = .2). However, a lower alpha diversity at 2 months of age was significantly associated with an increased risk for AD during the first 2 years in children with at least 1 parent (adjusted hazard ratio [aHR] 1.67; P = .03) or both parents (aHR 4.44; P = .04) with a history of atopy.

Study details: Findings are from a prospective analysis of 300 children born to term, of which 153 had a parental history of atopy.

Disclosures: This study was funded by The Leo Foundation and others. Some authors declared serving as speakers, advisors, or consultants for or receiving research grants or speaker or consulting honoraria from various organizations, including the study funders.

Source: Halling AS et al. Reduced skin microbiome diversity in infancy is associated with increased risk of atopic dermatitis in high-risk children. J Invest Dermatol. 2023 (Apr 19). Doi: 10.1016/j.jid.2023.03.1682

Recommended Reading

Facial, hand, and foot dermatitis: Lebrikizumab and dupilumab show efficacy in new studies
MDedge Dermatology
Expunging ‘penicillin allergy’: Your questions answered
MDedge Dermatology
Upadacitinib shows a favorable benefit-risk profile in adolescents with moderate-to-severe atopic dermatitis
MDedge Dermatology
Tralokinumab effective against moderate-to-severe atopic dermatitis in adolescents
MDedge Dermatology
Crisaborole induces normalization of mild-to-moderate atopic dermatitis proteome
MDedge Dermatology
Real-world study affirms benefits of dupilumab in pediatric patients with uncontrolled atopic dermatitis
MDedge Dermatology
A new emollient regimen improves pruritus in atopic dermatitis
MDedge Dermatology
Tralokinumab effective against moderate-to-severe atopic dermatitis in daily practice
MDedge Dermatology
An emollient plus balm offers corticosteroid-sparing effects in mild-to-moderate atopic dermatitis
MDedge Dermatology
Meta-analysis shows unidirectional association between atopic dermatitis and rheumatoid arthritis
MDedge Dermatology